Medidata Solutions, Inc. (MDSO) Research Coverage Started at Royal Bank Of Canada
Royal Bank Of Canada started coverage on shares of Medidata Solutions, Inc. (NASDAQ:MDSO) in a report issued on Tuesday, Marketbeat reports. The firm issued a sector perform rating and a $82.00 price target on the stock.
Several other research analysts also recently commented on the stock. Bank of America Corporation initiated coverage on shares of Medidata Solutions in a research note on Tuesday, June 6th. They issued a buy rating and a $85.00 price target on the stock. Zacks Investment Research downgraded shares of Medidata Solutions from a hold rating to a sell rating in a research note on Friday, July 21st. BidaskClub raised shares of Medidata Solutions from a hold rating to a buy rating in a research note on Wednesday, June 21st. J P Morgan Chase & Co raised their price target on shares of Medidata Solutions to $87.00 and gave the stock an overweight rating in a research note on Tuesday, July 18th. Finally, Citigroup Inc. reaffirmed a buy rating and issued a $95.00 price target (up previously from $94.00) on shares of Medidata Solutions in a research note on Monday, July 24th. Four analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. The company currently has an average rating of Buy and an average price target of $83.83.
Medidata Solutions (NASDAQ:MDSO) opened at 76.50 on Tuesday. Medidata Solutions has a 12 month low of $46.10 and a 12 month high of $85.92. The company’s 50 day moving average is $74.60 and its 200 day moving average is $70.33. The stock has a market cap of $4.33 billion, a PE ratio of 123.59 and a beta of 1.81.
Medidata Solutions (NASDAQ:MDSO) last posted its quarterly earnings results on Tuesday, July 18th. The company reported $0.31 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.28 by $0.03. The company had revenue of $137.41 million for the quarter, compared to the consensus estimate of $134.28 million. Medidata Solutions had a net margin of 7.07% and a return on equity of 11.14%. The firm’s revenue was up 19.9% compared to the same quarter last year. During the same quarter last year, the firm posted $0.24 EPS. On average, analysts anticipate that Medidata Solutions will post $1.28 EPS for the current fiscal year.
TRADEMARK VIOLATION WARNING: This news story was originally posted by Daily Political and is owned by of Daily Political. If you are reading this news story on another domain, it was illegally copied and republished in violation of U.S. & international trademark and copyright law. The legal version of this news story can be accessed at https://www.dailypolitical.com/2017/09/23/medidata-solutions-inc-mdso-research-coverage-started-at-royal-bank-of-canada.html.
In other Medidata Solutions news, COO Michael L. Capone sold 5,000 shares of the firm’s stock in a transaction dated Tuesday, August 15th. The shares were sold at an average price of $74.53, for a total transaction of $372,650.00. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 5.80% of the company’s stock.
Hedge funds and other institutional investors have recently bought and sold shares of the business. Zurcher Kantonalbank Zurich Cantonalbank increased its position in Medidata Solutions by 10.5% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,186 shares of the company’s stock valued at $171,000 after purchasing an additional 208 shares during the period. LS Investment Advisors LLC increased its position in Medidata Solutions by 44.6% during the 1st quarter. LS Investment Advisors LLC now owns 3,310 shares of the company’s stock valued at $191,000 after purchasing an additional 1,021 shares during the period. World Asset Management Inc purchased a new position in Medidata Solutions during the 1st quarter valued at about $201,000. Miles Capital Inc. bought a new stake in shares of Medidata Solutions in the 1st quarter valued at about $202,000. Finally, Oppenheimer & Close LLC bought a new stake in shares of Medidata Solutions in the 1st quarter valued at about $210,000. 97.52% of the stock is currently owned by institutional investors and hedge funds.
Medidata Solutions Company Profile
Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.
Receive News & Ratings for Medidata Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.